SUNNYVALE, Calif., March 24, 2026 (GLOBE NEWSWIRE) — BioCardia, Inc. [Nasdaq: BCDA], a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today reported financial results for the year ended December 31, 2025 and filed its annual report on Form 10-K with the Securities and Exchange Commission. The Company will host a corporate update conference call today, on Tuesday, March 24, 2026, at 4:30 PM ET, in which it will discuss business highlights. Call details and dial-in are provided below. Recent Business Highlights CardiAMP® autologous cell therapy in ischemic heart failure of reduced ejection fraction (BCDA-01) In parallel to advancing the regulatory discussions with the USA FDA and Japan PMDA on the potential market release of the CardiAMP System for the treatment...

Profitable Growth Initiatives Lead to Sequential Quarterly Improvement  Neal Cohane Appointed Interim Chief Executive Officer NORWALK, Conn., March 24, 2026 (GLOBE NEWSWIRE) — Reed’s, Inc. (NYSE American: REED) (“Reed’s” or the “Company”), owner of the nation’s leading portfolio of handcrafted, natural ginger beverages, today announced financial results for the three months and 12 months ended December 31, 2025. Additionally, the Company announced that Neal Cohane has been appointed to serve as interim Chief Executive Officer and member of the board of directors, effective today. Former CEO and Board Member Cyril Wallace has stepped down. The board has begun conducting a search for a permanent CEO. Leadership Transition Cohane is a highly accomplished and seasoned retail leader. He brings decades of leadership experience across...

Conference call scheduled for Tuesday, March 31, 2026 at 4:30 p.m. Eastern time DETROIT, March 24, 2026 (GLOBE NEWSWIRE) — Workhorse Group Inc. (NASDAQ: WKHS) (“Workhorse”) a North American OEM and provider of all-electric trucks, shuttles and buses, plans to conduct a conference call to discuss its fourth quarter and fiscal year 2025 results and business outlook on Tuesday, March 31, 2026, at 4:30 p.m. Eastern time. Prior to the conference call, Workhorse will issue its fourth quarter and fiscal year 2025 earnings press release. The press release may also be viewed on Workhorse’s website at ir.workhorse.com. To listen to the conference call webcast, please go to the Investor Relations section of Workhorse’s website. To listen via telephone, please call (877)-407-0789 (U.S.) or (201)-689-8562 (international). A telephonic replay...

Fourth quarter and full year results reflect temporary planned scale back in wholesale production At year-end was back to fully planted with legacy greenhouses and the most overall acreage planted in Glass House history Full year 2026 wholesale cannabis biomass production is forecasted to be approximately 1,000,000 pounds, up approximately 50% from 2025. Year-end 2025 cash and restricted cash balance was $23.4 million, forecasting year-end 2026 cash to exceed $50 million. Conference call to be held today March 24, 2026, at 5:00 p.m. ETLONG BEACH, Calif and TORONTO, March 24, 2026 (GLOBE NEWSWIRE) — Glass House Brands Inc. (“Glass House” or the “Company”) (CBOE CA: GLAS.A.U) (CBOE CA: GLAS.WT.U) (OTCQX: GLASF) (OTCQX: GHBWF), one of the fastest-growing, vertically integrated cannabis companies in the U.S., today reported financial...

Expands Board as Company Accelerates Growth in Solar Recycling and Critical Metals Recovery VIRGINIA CITY, Nev., March 24, 2026 (GLOBE NEWSWIRE) — Comstock Inc. (NYSE: LODE) (“Comstock,” “our” and the “Company”), today announced its full year 2025 results, 2025 summary achievements, and our 2026 business outlook. “Last year marked a number of critical achievements that punctuated the turnaround from a junior mining opportunity into a validated, leading metals recovery company positioned for global growth, including final proof of our zero-landfill recycling concept from our demonstration facility, team-building, full permitting, final, first-of-its-kind engineered and tested designs, secured industrial scale facility and storage capacity and fully funded the facility and operations while also receiving direct investment from Marathon...

MALVERN, Pa., March 24, 2026 (GLOBE NEWSWIRE) — TELA Bio, Inc. (“TELA Bio”), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today reported financial results for the fourth quarter and full year ended December 31, 2025. Recent HighlightsDelivered revenue of $20.9 million in the fourth quarter and $80.3 million for the full year 2025, an 18% and 16% increase, respectively, from the corresponding periods of 2024; Expanded the sales force to 88 quota-carrying representatives as of today under the leadership of commercial management added at midyear; Announcing promotion of Howard Langstein, MD, FACS to Chief Medical Officer, effective March 1, 2026; and Closed on a credit facility for up to $70.0 million from Perceptive Advisors (“Perceptive”). The Perceptive...

POMPANO BEACH, Fla., March 24, 2026 (GLOBE NEWSWIRE) — BioStem Technologies, Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacturing, and commercialization of perinatal tissue allograft products, today reported financial results for the fourth quarter and full year ended December 31, 2025. Recent Financial and Business HighlightsGenerated net revenue of $10.1 million for the fourth quarter 2025 and gross margin of 97% Completed the acquisition of the BioTissue Holdings Inc. surgical and wound assets in January 2026, significantly expanding the Company’s product portfolio, commercial footprint, and diversifying end markets into the hospital setting Integrated BioTissue’s experienced national sales force of approximately 20 direct sales representatives and managers, and more...

2025 Full-year results and business update Transgene Continues Progressto Reshape Early-Stage Cancer Treatmentthrough Individualized Neoantigen Therapeutic Vaccines (INTV) Backed by Financial Visibility Until Early 2028  TG4050, Transgene’s first INTV, demonstrated durable clinical outcomes in resected head and neck squamous cell carcinoma (HNSCC) and potential to prevent cancer relapseRandomization of Phase 2 patients nearly completed -Disease-free survival1 from evaluable patients in the Phase 2 part of the Phase 1/2 study expected 2 years after completion of randomization myvac® platform: new Phase 1 trial in a second indication in operable solid tumors planned to start in 2026 BT-001: Phase 1 results in patients with advanced refractory tumors support further clinical development €111.9 million in cash available as of December 31,...

MIAMI, March 24, 2026 (GLOBE NEWSWIRE) — Standard Premium Finance Holdings, Inc. (OTCQX: SPFX) (“Standard Premium”), a leading specialty finance company, today announces compelling financial and operational results for the 2025 fiscal year, highlighting growth in the Company’s receivables portfolio, net income, strong earnings per share (EPS) and double-digit return-on-equity. “These results demonstrate our continued ability to execute on a proactive growth strategy while maintaining strong financial discipline and the dedication of our team to continue achieving record-breaking profits,” says William Koppelmann, CEO, Standard Premium. “With a solid foundation in place, enhanced liquidity through our new credit facility and a focus on strategic expansion opportunities, we are well-positioned to drive sustained performance and deliver...

MINNETONKA, Minn., March 24, 2026 (GLOBE NEWSWIRE) — Table Trac, Inc. (OTCQX: TBTC), a developer and provider of casino information and management systems that automate and monitor the operations of casinos announced financial results for the year ended December 31, 2025. The 10-K can be found @ http://www.sec.gov 2025 Highlights Record Gross Profit. Record maintenance revenue of $6.15 Million, an approximate 14.4% increase over the prior year. Maintenance revenue accounted for 55.7% of total revenues. Other revenue increased 13.2% as a result of an increase in recurring monthly fees relating to DataTrac and SlotSuite. Table Trac declared and paid quarterly dividends of $0.02 per share in each of the four quarters during 2025. The CasinoTrac system was installed in eight locations during 2025. At the end of 2025, Table Trac had...